Leukemia Research 1993-04-01

Effects of dolastatins on human B-lymphocytic leukemia cell lines.

Z B Hu, S M Gignac, H Quentmeier, G R Pettit, H G Drexler

Index: Leuk. Res. 17(4) , 333-9, (1993)

Full Text: HTML

Abstract

Dolastatins are naturally occurring peptides isolated from marine animals and are known to be potent anti-neoplastic agents. Here, the three compounds dolastatin 10 (Dola 10), dolastatin 15 (Dola 15) and deo-dolastatin 10 (Deo-Dola 10) were added to cultures of two human chronic B-leukemia cell lines, JVM-2 and EHEB. The three dolastatins (Dola 10 > Dola 15 > Deo-Dola 10) inhibited cell proliferation and immunoglobulin production. Decreased cell growth and lack of accumulation of immunoglobulin was not caused by cytotoxicity as cell viability in the cultures remained high. The unchanged surface marker immunoprofiles during treatment and a predominance of treated cells in S and G2/M phase suggested cytostatic rather than directly cytotoxic effects. Exposure to these reagents increased quickly, albeit only short c-myc and bcl-2 mRNA expression. These results indicate that the three dolastatins are potent inhibitors of leukemic B-cell proliferation.

Related Compounds

  • Dolastatin 15

Related Articles:

End-binding proteins sensitize microtubules to the action of microtubule-targeting agents.

2013-05-28

[Proc. Natl. Acad. Sci. U. S. A. 110(22) , 8900-5, (2013)]

The bcl-2 and p53 oncoproteins can be modulated by bryostatin 1 and dolastatins in human diffuse large cell lymphoma.

1995-06-01

[Anticancer Drugs 6(3) , 392-7, (1995)]

Targeting HER2-positive cancer with dolastatin 15 derivatives conjugated to trastuzumab, novel antibody-drug conjugates.

2012-09-01

[Cancer Chemother. Pharmacol. 70(3) , 439-49, (2012)]

Quantitation of dolastatin-10 using HPLC/electrospray ionization mass spectrometry: application in a phase I clinical trial.

1998-01-01

[Cancer Chemother. Pharmacol. 41(4) , 299-306, (1998)]

A natural peptide, dolastatin 15, induces G2/M cell cycle arrest and apoptosis of human multiple myeloma cells.

2007-06-01

[Int. J. Oncol. 30(6) , 1453-9, (2007)]

More Articles...